ID   OSCC-BD
AC   CVCL_2H27
DR   Wikidata; Q54936705
RX   PubMed=26234610;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Leu188_Pro191del (c.563_574del12); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI:59032; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Transformant: ChEBI; CHEBI:29865; Benzo[a]pyrene.
CC   Omics: Proteome analysis.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C129863; Oral epithelial dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1180 ! DOK
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 12
//
RX   PubMed=26234610; DOI=10.1038/srep12668;
RA   Dong Y., Zhao Q., Ma X.-Y., Ma G.-W., Liu C.-Y., Chen Z.-W., Yu L.-Y.,
RA   Liu X.-F., Zhang Y.-G., Shao S.-J., Xiao J., Li J., Zhang W.-M., Fu M.,
RA   Dong L.-J., Yang X.-D., Guo X., Xue L.-Y., Fang F., Zhan Q.-M.,
RA   Zhang L.-H.;
RT   "Establishment of a new OSCC cell line derived from OLK and
RT   identification of malignant transformation-related proteins by
RT   differential proteomics approach.";
RL   Sci. Rep. 5:12668-12668(2015).
//